Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 10 Jun 20 EFFECT Notice of effectiveness
- 4 Jun 20 POS AM Prospectus update (post-effective amendment)
- 11 May 20 424B3 Prospectus supplement
- 21 Apr 20 424B3 Prospectus supplement
- 24 Mar 20 EFFECT Notice of effectiveness
- 13 Mar 20 POS AM Prospectus update (post-effective amendment)
- 23 Dec 19 424B4 Prospectus supplement with pricing info
- 23 Dec 19 EFFECT Notice of effectiveness
- 19 Dec 19 S-1/A IPO registration (amended)
-
13 Dec 19 S-1 IPO registration
APLT similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated March 8, 2019 (except for Note 12, as to which the date is April 29, 2019) in the Registration Statement (Form S-1) and related Prospectus of Applied Therapeutics, Inc. for the registration of 1,380,344 shares of its common stock.
/s/ Ernst & Young LLP
New York, New York
December 13, 2019
Consent of Independent Registered Public Accounting Firm